Accordingly, EA administration significantly reduced cardiac tissue levels of pro-inflammatory cytokines (IL-6 and IL-1β) and elevated anti-inflammatory cytokines (IL-10 and IL-4) in DCM rats. The gene discussed is IL6; the disease is familial dilated cardiomyopathy.